Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

This study is currently recruiting participants.

Study NCT00933231 Information provided by Astellas Pharma Inc

First Received: July 2, 2009 Last Updated: December 9, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2017
Estimated Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)